Legal & General Group’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $981K | Buy |
68,098
+62,871
| +1,203% | +$906K | ﹤0.01% | 2246 |
|
|
2025
Q1 | $36.1K | Hold |
5,227
| – | – | ﹤0.01% | 2770 |
|
|
2024
Q4 | $27.7K | Sell |
5,227
-199
| -4% | -$1.06K | ﹤0.01% | 2914 |
|
|
2024
Q3 | $19.8K | Hold |
5,426
| – | – | ﹤0.01% | 3053 |
|
|
2024
Q2 | $14.9K | Buy |
+5,426
| New | +$14.9K | ﹤0.01% | 3147 |
|
|
2022
Q3 | – | Sell |
-3,744
| Closed | -$6K | – | 3497 |
|
|
2022
Q2 | $6K | Sell |
3,744
-1,134
| -23% | -$1.82K | ﹤0.01% | 3436 |
|
|
2022
Q1 | $12K | Hold |
4,878
| – | – | ﹤0.01% | 3371 |
|
|
2021
Q4 | $18K | Hold |
4,878
| – | – | ﹤0.01% | 3315 |
|
|
2021
Q3 | $31K | Hold |
4,878
| – | – | ﹤0.01% | 3121 |
|
|
2021
Q2 | $48K | Buy |
4,878
+481
| +11% | +$4.73K | ﹤0.01% | 2965 |
|
|
2021
Q1 | $41K | Sell |
4,397
-582
| -12% | -$5.43K | ﹤0.01% | 2886 |
|
|
2020
Q4 | $24K | Hold |
4,979
| – | – | ﹤0.01% | 3025 |
|
|
2020
Q3 | $20K | Sell |
4,979
-2,018
| -29% | -$8.11K | ﹤0.01% | 2975 |
|
|
2020
Q2 | $32K | Buy |
6,997
+9
| +0.1% | +$41 | ﹤0.01% | 2867 |
|
|
2020
Q1 | $23K | Sell |
6,988
-1,716
| -20% | -$5.65K | ﹤0.01% | 2865 |
|
|
2019
Q4 | $38K | Buy |
8,704
+2,976
| +52% | +$13K | ﹤0.01% | 2933 |
|
|
2019
Q3 | $23K | Hold |
5,728
| – | – | ﹤0.01% | 3093 |
|
|
2019
Q2 | $27K | Hold |
5,728
| – | – | ﹤0.01% | 3085 |
|
|
2019
Q1 | $24K | Hold |
5,728
| – | – | ﹤0.01% | 3035 |
|
|
2018
Q4 | $20K | Hold |
5,728
| – | – | ﹤0.01% | 3087 |
|
|
2018
Q3 | $25K | Hold |
5,728
| – | – | ﹤0.01% | 3123 |
|
|
2018
Q2 | $21K | Buy |
+5,728
| New | +$21K | ﹤0.01% | 3181 |
|
|
2017
Q2 | – | Sell |
-4,744
| Closed | -$13K | – | 3389 |
|
|
2017
Q1 | $13K | Buy |
4,744
+1,962
| +71% | +$5.38K | ﹤0.01% | 3163 |
|
|
2016
Q4 | $9K | Buy |
+2,782
| New | +$9K | ﹤0.01% | 3231 |
|